– Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity.
– S1C[C@@H](C(N[C@H](C(N[C@H](C(N[C@@H](C)C(N[C@@H]([C@@H](C)O)C(N[C@@H](CS1)C(N[C@@H](C)C(N[C@@H]([C@@H](C)O)C(N[C@@H](CCC(N)=O)C(N[C@H](C(N[C@H](C(N[C@@H](C)C(N[C@@H](CCC(=O)O)C(N[C@@H](CC1C=CC=CC=1)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(=N)N)C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@H](CC(N)=O)C(N[C@@H](CC1C=CC=CC=1)C(NCC(N1CCC[C@H]1C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(C)C)C(N1CCC[C@H]1C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H]([C@@H](C)O)C(N1CCC[C@H]1C(N)=O)=O)=O)=O)CO)=O)=O)C(C)C)=O)CC(N)=O)=O)[C@@H](C)O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC(C)C)=O)CCCNC(=N)N)=O)=O)=O)=O)=O)=O)=O)[C@@H](C)O)=O)CC(N)=O)=O)NC([C@H](CCCCN)NC(CC[C@@H](C(=O)O)NC(CCCCCCCCCCCCCCCCCCC(=O)O)=O)=O)=O